The Recall Desk
ModerateFDA (Drugs)·D-0418-2025·Announced 2025-05-21

La Roche-Posay Effaclar Acne Treatment Kits Recalled Nationwide

L'Oreal USA is recalling La Roche-Posay Effaclar 3-Step Acne Routine Kits nationwide due to trace levels of benzene detected in one lot. As a precaution, all Effaclar Duo Dual Action Acne Treatment lots are included in the recall.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall with a voluntary precautionary scope. Benzene was detected at trace levels in only one lot, and no illnesses or injuries have been reported. The hazard is theoretical, placing this in the Moderate category.

Plain-English summary

L'Oreal USA is voluntarily recalling La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System 3-Step Acne Routine Kits, distributed nationwide in the USA. The kits contain Medicated Gel Cleanser (3.4 fl. oz.), Clarifying Solution (3.4 fl. oz.), and Dual Action Acne Treatment (0.7 fl. oz.), with UPC 883140035282. Approximately 14,460 bottles are affected.

The recall was initiated after trace levels of benzene were detected in lot MYX46W. Out of an abundance of caution, the firm has voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots with the affected lot numbers and expiration dates listed by the FDA.

Consumers who have purchased affected kits should stop using them and consult with a healthcare provider if they have questions or concerns. Consumers may contact L'Oreal USA at 10 Hudson Yards, New York, NY 10001, or the FDA for further information.

The recalled product

Product
La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit, Medicated Gel Cleanser 3.4 fl. oz. (100 mL) Tube, Clarifying Solution 3.4 fl. oz. (100 mL) Tube, Dual Action Acne Treatment 0.7 fl. oz. (20 mL: UPC 883140035275) Tube, (benzoyl
Manufacturer
L'Oreal USA
Category
Drug — Topical Acne Treatment
Hazard
Affected units
14,460

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • Lot #s
  • Expiration Dates: MYX30W
  • Exp 03/31/2025 MYX32W
  • Exp 03/31/2025 MYX33W
  • Exp 03/31/2025 MYX41W
  • Exp 04/30/2025 MYX42W
  • Exp 04/30/2025 MYX43W
  • Exp 04/30/2025 MYX44W
  • Exp 04/30/2025 MYX45W
  • Exp 04/30/2025 MYX50W
  • Exp 05/31/2025 MYX51W
  • Exp 04/30/2025 MYX52W
  • Exp 04/30/2025 MYX53W
  • Exp 05/31/2025 MYX70W
  • Exp 07/31/2025 MYX80W
  • Exp 07/31/2025 MYX81W
  • Exp 07/31/2025 MYX90W
  • Exp 08/31/2025 MYX91W
  • Exp 08/31/2025 MYX92W
  • Exp 08/31/2025 MYX93W

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 3 recalled by L'Oreal USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →

Related recalls

Same manufacturer · L'Oreal USA

See all →

Same hazard · benzene

See all →